Aktuellt
SENASTE
Q-linea finishes 2023 on a positive note as the company has placed the first two US ASTar systems. These are RUO (Research Use Only) orders and at this stage the Hospitals (Labs) are not disclosed. We expect further details to be revealed later in 2024 when the results from RUO testing are made public. Jim Kathrein, VP of Commercial Operations refers to strong interest in ASTar. Our Base Case is SEK 9 (Bull SEK 35 and Bear SEK 1).
LÄS MER
